Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
0.6603
-0.0307 (-4.44%)
At close: Mar 26, 2026, 4:00 PM EDT
0.6600
-0.0003 (-0.05%)
Pre-market: Mar 27, 2026, 5:52 AM EDT
Biodexa Pharmaceuticals Market Cap
Biodexa Pharmaceuticals has a market cap or net worth of $4.09 million as of March 27, 2026. Its market cap has increased by 171.93% in one year.
Market Cap
4.09M
Enterprise Value
-752.42K
1-Year Change
171.93%
Ranking
Category
Stock Price
$0.66
Market Cap Chart
Since October 28, 2016, Biodexa Pharmaceuticals's market cap has decreased from $55.80M to $4.09M, a decrease of -92.67%. That is a compound annual growth rate of -24.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 579.60K | -69.56% |
| Dec 31, 2025 | 1.90M | -19.06% |
| Dec 31, 2024 | 2.35M | -66.49% |
| Dec 29, 2023 | 7.02M | 64.98% |
| Dec 30, 2022 | 4.26M | -67.32% |
| Dec 31, 2021 | 13.02M | -43.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silexion Therapeutics | 4.46M |
| Azitra | 4.44M |
| Genprex | 4.38M |
| Artelo Biosciences | 4.26M |
| VivoSim Labs | 4.22M |
| Revelation Biosciences | 4.17M |
| Aspire Biopharma Holdings | 4.03M |
| Aptevo Therapeutics | 3.95M |